Intuitive Surgical, Inc. $ISRG is Woodstock Corp’s 6th Largest Position

Woodstock Corp cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 82,619 shares of the medical equipment provider’s stock after selling 1,653 shares during the period. Intuitive Surgical comprises 3.2% of Woodstock Corp’s portfolio, making the stock its 6th biggest holding. Woodstock Corp’s holdings in Intuitive Surgical were worth $36,950,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $27,000. TD Capital Management LLC increased its position in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, insider Gary S. Guthart sold 22,806 shares of the company’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $570.89, for a total value of $13,019,717.34. Following the completion of the transaction, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. This represents a 89.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last three months. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Citigroup cut Intuitive Surgical from a “buy” rating to a “neutral” rating and reduced their target price for the company from $650.00 to $635.00 in a research note on Thursday, December 11th. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Jefferies Financial Group upped their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Piper Sandler lifted their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Finally, The Goldman Sachs Group boosted their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $609.83.

Intuitive Surgical Trading Down 0.9%

ISRG stock opened at $554.58 on Wednesday. The firm’s 50-day moving average price is $534.09 and its two-hundred day moving average price is $505.41. The stock has a market capitalization of $198.81 billion, a price-to-earnings ratio of 73.36, a PEG ratio of 5.14 and a beta of 1.68. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.84 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.